Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/16/17 → 10/31/19 |
Funding
- Syneos Health, Inc. (Prot #SB-STR02 // Prot #SB-STR02)
- Sunovion Pharmaceuticals Inc. (Prot #SB-STR02 // Prot #SB-STR02)
Prot #SB-STR02: A Double-Blind, Controlled Phase 2B Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Ischemic Stroke
- Rosenow, Joshua M (PD/PI)
Project: Research project